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Abstract: Glial cells coordinate the differentiation, metabolism, and excitability of neurons; they modulate synaptic   
transmission and integrate signals emanating from neurons and other glial cells. Several evidences underlying the relation 
between these pathways and the regulatory mechanisms of ion concentration, supporting the role of Aquaporins (AQPs) in 
these processes.  
The goal of this review is to summarize the localization of different isoforms of AQPs in relation to glial cells both in  
central and peripheral nervous system, underlying AQP involvement in physiological and in pathophysiological   
conditions such as brain edema, glioma and epilepsy.  
Keywords: Aquaporins, glial cells.  
1. GENERAL CONCEPTS 
  Maintenance of a stable internal osmotic environment is 
essential for normal cerebral activity [85].  
  Astrocytes, that are the most numerous glial cell type and 
account for one third of brain mass [35], are involved in the 
maintenance of the blood–brain barrier (BBB), in the regula-
tion of water and ion homeostasis and aminoacid neuro-
transmitter metabolism, as well as energy and nutrient   
support of neurons. Of particular importance is regulatory 
volume decrease that allows cells to remove excess water 
from their cytoplasm in attempt to maintain a proper water 
balance. In particular water extrusion occurs through special-
ized water channels called Aquaporins (AQPs) [74],   
although in some cells water permeates lipid membranes 
directly [109] or passes the membrane through unrelated 
channels [27].  
  The expression of six isoforms of AQP protein (AQP1, 3, 
4, 5, 8, 9) has been reported in the glial cells Table 1, being 
identified in astrocytes (AQP1, 3, 4, 5, 8, 9), oligodendro-
cytes (AQP8), tanycytes (AQP9) and ependymal cells 
(AQP1, 4, 9) [5, 40, 49, 52, 58, 63, 93]. Moreover a recent 
study demonstrated the expression of AQP4 mRNA and   
protein within reactive microglial cells in vivo [95].  
  Although numerous studies have reported AQP localiza-
tion and function in the central nervous system (CNS), little 
is known about the expression and function of AQPs in the 
peripheral nervous system (PNS). In particular, there has 
been controversy over the localization of AQP1 in the PNS. 
Nevertheless, Gao and co-workers [28] reported AQP1 ex-
pression in glial elements while more recent studies have 
demonstrated the presence of neural elements positive for 
AQP1 in the enteric nervous system [54]. Moreover AQP1  
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was found in the PNS of dorsal root, trigeminal and nodose 
ganglia [57, 67, 84]. AQP2 expression was recently reported 
also in Schwann cells of dorsal root and trigeminal ganglia 
during pain condition [12, 13]. 
Table 1.  Localization of Aquaporins in Glial Cells 
AQP isoform  Glial localization 
AQP1  astrocytes, ependymal cells, Schwann cells,  
satellite cells 
AQP2  ependymal cells, Schwann cells, satellite cells 
AQP3 astrocytes 
AQP4  astrocytes, ependymal cells, microglial cells 
AQP5 astrocytes 
AQP8  astrocytes and ependymal cells of spinal cord,  
oligodendrocytes  
AQP9  astrocytes, ependymal cells, tanycytes 
Table 1. Table representing the different isoforms of aquaporin protein in the glial cells 
of central and peripheral nervous system.  
  These findings suggest that members of the AQP family 
are differentially expressed in the peripheral versus CNS. 
2. AQUAPORINS AND GLIAL CELLS 
2.1. AQP1 
  AQP1 mediates water transport in several organs where  
it plays an important role, such as the formation of urine and 
aqueous humor in the eye [97, 110] or cerebrospinal fluid 
(CSF) in the brain. Brain AQP1 is mainly expressed in the 
CSF-facing membranes of the ventricular choroid plexus, 
where it regulates the formation of CSF, partly because of its 
ion channel function [66, 87].  Aquaporins and Glia  Current Neuropharmacology, 2010, Vol. 8, No. 2    85 
  Increasing evidences indicate that brain astrocytes ex-
press AQP1 under pathologic conditions. AQP1 is found in 
reactive astrocytes accumulating in the lesions of subarach-
noid hemorrhage [3], contusion [92], Creutzfeldt-Jacob dis-
ease [79], cerebral infarction and multiple sclerosis [82]. 
Moreover, a recent study showed that the expression of   
this protein is increased in cortical astrocytes at the early 
stage of Alzheimer disease, suggesting a pathological role   
of abnormal regulation of water transport in this condition 
[73].  
  After spinal cord injury (SCI) there was evidence that 
reactive astrocytes show a significant increase of AQP1 ex-
pression surrounding the lesion site, while reactive astrocytes 
distant from the lesion express markedly less it [58]. So, 
given that hypoxia stimulates astrocytic migration [106] it is 
possible that hypoxic conditions after SCI trigger AQP1 syn-
thesis in astrocytes, as an attempt of injured spinal cords to 
facilitate astrocytic migration to the lesion site. A role for 
AQPs in facilitating cell migration was first reported for 
AQP1 and vascular endothelial cells in mice implanted with 
melanoma tumours [81]. Nevertheless, molecular mecha-
nisms responsible for AQP involvement in cell migration are 
unknown. Two theories have recently been suggested [71]: 
according to the first theory actin depolymerisation and ion 
influx at the leading edge of migrating cells increase local 
cytoplasm osmolarity, thus promoting water influx through 
the cell membrane, facilitated by AQPs, causing a local rise 
in hydrostatic pressure that expands the cell membrane. 
Then, actin repolymerisation stabilizes the membrane protru-
sion. According to the second theory, migrating cells un-
dergo rapid changes in cell shape and cell volume as they 
move through the irregularly shaped brain extracellular space 
(ECS) between stationary cells. AQPs accelerate cell migra-
tion by facilitating the transmembrane water fluxes that me-
diate such cell volume changes. AQP1 is expressed also in 
the ependymal cells of spinal cord around the central canal 
and more robustly in  the sensory fibers of the superficial 
laminae of the dorsal horn [84]. Its levels was significantly 
and persistently elevated for up to 11 months after SCI in 
sensory axons, neurons but also in astrocytes and ependymal 
cells, despite considerable loss of neurons and axons at the 
site of injury [58]. Hypoxic conditions may contribute to 
chronic accumulation of water within neurons and cytotoxic 
edema that can account for the increased water content in 
chronically injured spinal cords, given that the antioxidant 
melatonin significantly decreases AQP1 expression induced 
by SCI [59]. Sustained up-regulation of AQP1 in ependymal 
cells may result in the over-production of CSF and formation 
of CSF-filled cysts after SCI, a serious and untreatable   
complication of SCI [23]. In fact, it has already been shown 
that AQP1 has a role in the formation of CSF-filled cysts  
[7, 44].  
  Moreover, AQP1 may play during the intake of water 
that precedes axonal elongation. Nesic et al. [58] demon-
strated that the pattern of AQP1 expression in the dorsal 
horns was similar to that of GAP-43, important in axonal 
growth during embryogenesis, in synaptic remodeling and 
plasticity and in regeneration after injury [15, 36]. GAP-43 
that resides in the growth cones of growing neuritis where it 
interacts with F-actin-associated adhesion molecules and/or 
extracellular matrix complexes to promote neurite extension 
[31], co-localized with AQP1 in both uninjured and injured 
spinal cords. AQP1 and GAP-43 labeling were found in par-
ticular within unmyelinated, small-diameter nerve fibers in 
the superficial laminae of the dorsal horns; this indicates a 
high degree of plasticity of sensory axons. Therefore AQP1 
expression in spinal cord may have a role in axonal remodel-
ing and plasticity, necessary for normal sensory processing.  
  In brain tumours AQP1 expression increases with the 
grade of malignancy [64, 81]. In glioblastoma multiformes, 
in addition to vascular alterations, there are important meta-
bolic changes compared to normal brain tissue. In fact, 
glioma cells can engage in high rates of aerobic glycolysis, 
resulting in increased glucose consumption and production 
of lactic acid even under normoxia [45]. The increase in lac-
tic acid production and subsequent acidification of extracel-
lular space likely contribute to the invasive potential of can-
cer cells [29]. The ability of cells to transport excess H
+ from 
intracellular to extracellular space may also require move-
ment of H2O in the same direction [34], suggesting another 
potential function for AQP1 in brain tumours, besides to 
contribute to vasogenic edema formation.  
  In the PNS satellite cells of the trigeminal ganglia of rat 
show AQP1 expression [57] (Fig. (1)). Glial Fibrillary 
Acidic Protein (GFAP)-positive Schwann cells are known to 
express AQP1 too [28, 57] (Fig. (1)) but high resolution 
studies using electron microscopy are needed to determine 
the nature of AQP1-positive cells in nerve bundles and   
the detailed subcellular localization of AQP1 in both nerve 
plexuses and bundles in the PNS. 
2.2. AQP2 
  Many studies suggest that AQP2 is exclusively expressed 
in the renal collecting duct [37] but there is increasing of 
evidence that AQP2 is also expressed in several extra-renal 
locations such as the male reproductive tract [89], the inner 
ear [51], pancreatic islets, selected cells in gastric pits, intes-
tinal and colonic epithelium and fallopian tubes [89]. 
  Mobasheri and co-workers [53] reported that in the CNS 
AQP2 was found also in selected regions of the CNS includ-
ing ependymal cell layer, spinal cord, subcortical white mat-
ter and hippocampus. 
 Moreover  Borsani  et al. [12] in a murine inflammatory 
pain model showed for the first time that AQP2 is expressed 
also in Schwann and satellite cells of trigeminal ganglia, 
while in normal condition it is not found. Moreover, after 
chronic constriction of sciatic nerve (CCI) in rat, AQP2 ex-
pression increased in small-diameter dorsal root ganglia neu-
rons but also in Schwann cells [13]. On the basis of these 
data AQP2 may be involved in pain transmission in the PNS. 
In fact, many studies have provided indirect evidence of the 
contribution of osmosis in the pain pathway. Moreover, 
AQP2 could be involved in cellular processes characterized 
by ion influx like transduction of signal injury, nerve con-
duction and synaptic transmission. 
2.3. AQP3 
  Unique evidence of AQP3 expression in glial cells was 
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protection assay and reverse transcription-polymerase reac-
tion (RT-PCR) they found AQP3 expression in astrocytes as 













Fig. (1). Immunofluorescent images of the periodontal ligament 
(a-b) and of the trigeminal ganglia (c-d) of rat. AQP1 expression 
(red) in the periodontal Ruffini endings (a), in particular in den-
dritic axon profiles including microprojections (blue arrows) and 
round cell bodies of the terminal Schwann cells (white arrows) and 
in trigeminal ganglia (c), in particular in satellite cells (arrows) and 
trigeminal neurons (asterisk). Double immunostaining with AQP1 
(red) and S-100 protein (green) (b), indicates the co-localization of 
AQP1 with S-100 protein in the cell membrane of the terminal 
Schwann cells and their cytoplasmic extensions (arrowheads). The 
nuclei of the terminal Schwann cells (asterisks) lack AQP1 im-
munoreaction. Double immunostaining with AQP1 (red) and 
PGP9.5 (green) (d), indicates the localization of AQP1 in satellite 
cells while asterisk in trigeminal neurons. Scale bar: 25 μm (a-b); 
75 μm (c-d). Figures from Nandasena et al. [57], reprinted with 
permission of Elsevier. 
2.4. AQP4 
  A general paradigm is that AQP4 is not expressed in   
excitable cells, but is found in supporting cells as astrocytes 
and ependyma in the nervous system and Muller glia in the 
retina. In fact, it is strongly expressed at the borders between 
brain parenchyma and major fluid compartments including 
astrocytes foot processes (brain-blood), glia limitans (brain-
subarachnoid CSF), as well as ependymal cells and subepen-
dymal astrocytes (brain-ventricular CSF) [63, 78].  
  The osmosensitive organs display a unique pattern of 
AQP4 compartmentation [63]. In these organs the astrocytes 
form lamellae that contain high concentrations of AQP4,   
also at sites that do not face the brain surface or capillaries. 
Although AQP4 expression is polarized in astrocytes foot 
processes adjacent to endothelial cells, in the absence of en-
dothelia (e.g. cultured astrocytes and malignant astrocytes) 
[78, 80, 105] AQP4 redistributes throughout the astrocyte 
cell membrane, suggesting that endothelial cells signal astro-
cytes to polarize AQP4 expression in the cell membrane 
[93]. 
  Recent study using AQP4 knock-out mice indicated that 
AQP4 is involved in the formation and resolution of brain 
and spinal cord edemas [47, 69, 70]. Compared to normal 
mice, AQP4 knock-out mice exhibit reduced brain edema 
and neurologic improvement following ischemic brain injury 
[46, 99]; in these animals the rate of osmotic swelling is sig-
nificantly reduced in the deeper lamina of the dorsal horn of 
the spinal cord [86]. In fact it may favor high transmembrane 
fluxes of water with minimal osmotic perturbation [6]. 
  In general AQP4 expression is up-regulated in astrocytes 
associated with brain edema. For exemple, AQP4 over-
expression in human astrocytomas correlates with the pres-
ence of brain edema on magnetic resonance scans [80]. Cor-
relations between AQP4 expression and brain edema have 
been reported after brain ischaemia [17, 50], and traumatic 
brain injury in rodents [17, 91]. Moreover, in glioblastoma it 
was recently demonstrated an up-regulation and redistribu-
tion of AQP4 accompanied by a loss of its polarized expres-
sion pattern and so the evidence for a role of it in vasogenic 
edema formation [80, 102, 104]. 
  AQP4 also facilitates the elimination of excess brain wa-
ter. Excess water is eliminated primarily through the glia 
limiting membranes into the CSF. Greater brain water accu-
mulation and intracranial pressure were found in AQP4 
knock-out versus wild-type mice with brain tumour, brain 
abscess, focal cortical-freeze injury, and after infusion of 
normal saline directly into brain extracellular space [11, 69, 
70], indicating that vasogenic edema fluid is eliminated by 
an AQP4-dependent route. Also, in a kaolin injection model 
of obstructive hydrocephalus, AQP4 knock-out mice develop 
more marked hydrocephalus than wild-type mice [10], 
probably due to reduced water clearance through the epen-
dymal and BBB. Moreover, animal models imply a protec-
tive effect of AQP4 by facilitating excess fluid assembled in 
the brain parenchyma after BBB disruption [69, 70]. 
  Changes in astrocyte shape and function are known also 
to occur in association with human immunodeficiency virus 
(HIV) dementia (HIVD). Using Western Blot analysis, Hil-
laire and collaborators [88] showed that immunoreactivity 
for AQP4 is elevated in brain homogenates from the mid 
frontal gyrus of patients who died with HIVD. Of interest, a 
significant increase is observed in homogenates from HIV-
infected individuals without dementia too. Nevertheless, 
additional studies are necessary to determine whether altered 
AQP4 expression represents a protective and/or maladaptive 
response to CNS inflammation. 
  Recent studies have found also changes in astroglia Kir 
channels and AQP4 water channels in temporal lobe epilepsy 
specimens [9]. Alterations in astroglial water regulation 
could, in fact, powerfully affect excitability. Brain tissue 
excitability is sensitive to osmolarity and size of the ECS 
[83]. Decreasing ECS volume produces hyperexcitability and 
enhanced epileptiform activity [16, 19, 68], while increasing 
ECS volume with hyperosmolar medium attenuates epilepti-
form activity [19, 68]. Several lines of evidence support the 
hypothesis that AQP4 and Kir4.1 may act in concert in K
+ 
and H2O regulation [85]. In fact, K
+ re-uptake into glial cells 
could be AQP4-dependent, as water influx coupled to K
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influx is thought to underlie activity-induced glial cell swel-
ling [100, 101]. In addition studies in the retina have demon-
strated subcellular co-localization of AQP4 and Kir4.1 via 
both electron microscopic and co-immunoprecipitation 
analyses [18, 55] while Kir4.1
-/- mice showed impaired reti-
nal and cochlear physiology presumably due to altered K
+ 
metabolism [42, 43, 48]. Moreover, afferent stimulation of 
hippocampal slices from -syntrophin-deficient mice dem-
onstrates a deficit in extracellular K
+ clearance [2]. These 
data are consistent with the idea that AQP4 and Kir4.1 par-
ticipate in clearance of K
+ following neural activity. Eid and 
collaborates [21] reported that the loss of perivascular AQP4 
in mesial temporal lobe of patients with epilepsy results in a 
perturbed flux of water through astrocytes leading to an im-
paired buffering of extracellular K
+ and an increased propen-
sity for seizure. Nevertheless, another study reported that a 
significant increase in AQP4 is observed in sclerotic, but not 
in non-sclerotic, hippocampi obtained from patients with 
medically intractable temporal lobe epilepsy [39]. However, 
further studies are required to clarify the expression and 
functional interaction of AQP4 and Kir4.1 in the hippocam-
pus and their changes during epileptogenesis. 
  AQP4 seems to be involved also in autism. In fact, while 
earlier studies did not show evidence of astrogliosis or mi-
croglial activation [8], more recent works have suggested a 
role for neuroglial activation in autism [38, 72]. Several re-
cent reports have showed evidence for astroglial activation in 
cerebellum, frontal, and cingulate cortex [25, 38, 98], adding 
to the weight of pathologic evidence in favor of immune 
dysregulation in brains of autistic subjects.  
  Pardo and co-workers [72] suggested that, while it is un-
clear how and when microglia and astroglia become acti-
vated, it may result from intrinsic disturbances in neuroglial 
function or neuronal-neuroglial interactions during brain 
development or from extrinsic effects resulting from un-
known factors that disturb prenatal or postnatal development. 
A role for neuroglial activation in autism is suggested by 
altered expression of GFAP, a marker of astroglial in brain 
[1, 98] and CSF [1] of subjects with autism. In addition to 
GFAP, altered expression of AQP4 has been associated with 
this neurologic disease; in particular AQP4 expression was 
decreased in cerebellum of subjects with autism. Prenatal 
influence infection in mice results in a down-regulation of 
AQP4 expression in the offspring at birth [26] that persists  
at adolescence [24]. Decreased AQP4 expression may   
mean that cell structure, cell volume and ionic homeostatis 
are compromised. Nicchia and co-workers [62] showed   
that cultured astrocytes from AQP4 knock-out mice had   
altered morphology and reduced osmotic permeability. These 
changes suggest abnormal glial-neuronal communication in 
brains of subjects with autism. 
  AQP4 is abundantly expressed in the basolateral mem-
brane of the ependyma and glia limitans lining subependy-
mal layer and pia. This distribution feature indicates that 
AQP4 provides a highly efficient pathway to convey the 
redundant water from parenchyma to ventricle system and 
subarachnoid space [3, 30, 63]. The highly polarized expres-
sion of AQP4 suggests it may be involved in maintaining the 
structural and functional integrity of the ependyma. Immu-
nohistochemistry and electromicroscopy demonstrated that 
AQP4 deletion resulted in decreased expression of gap junc-
tion protein connexin43 (Cx43) [41], that is the main gap-
junction protein in astrocytes as well as ependymal cells 
[77].  
  Tomas-Camardiel and colleagues [95] provided for the 
first time direct evidence demonstrating the expression of 
AQP4 mRNA and protein within reactive microglial cells in 
vivo. In fact the intranigral injection of lipopolysaccharide, 
that mimics the BBB disruption in memingoencephalitis [75] 
and provokes severe vasogenic brain edema, produced an 
area of disappearance of astrocytes probably due to the open-
ing of the BBB which filled with reactive microglia express-
ing AQP4 mRNA and protein. With no exception, all 
vimentin-labelled in the astrocytes depleted area exhibited a 
pseudopodic to globular-shaped morphology, typical of reac-
tive microglia [76, 90]. It is possible that all cells expressing 
AQP4 expression within microglial cells may represent a 
molecular adaptation to maintain ion water homeostasis in 
the injured brain. The loss of astrocytes and proliferation of 
activated microglia could suggest that activated microglia is 
implicated in the clearance of potassium ions (K
+) and resto-
ration of osmotic equilibrium in absence of astrocytes. It is 
well known, in fact, that glial cells play an important role in 
regulating the homeostasis to ensure an appropriate neuronal 
environment. The astrocytes may help clear excess K
+ 
around active neuron [60] and in this context AQP4 seems to 
play an essential role [56].  
2.5. AQP5 
  In the CNS AQP5 was detected in astrocytes and in neu-
rons [108]. In primary cultures of rat astrocytes, the treat-
ment with dibutyryladenosine 3’, 5’-cyclic monophosphate 
(dbcAMP), an protein kinase A (PKA) activator, caused de-
creases in AQP5 mRNA and protein in time- and concentra-
tion-dependent manners [107]. Moreover, the effects of 
dbcAMP on the cells were inhibited by pretreatment with 
PKA inhibitor suggesting that AQP5 is regulated from PKA 
[107], one of the major signal transduction pathways in as-
trocytes regulating cell growth, mRNA expression and en-
zyme activation [4, 20]. Interestingly, AQP5 showed a tran-
sient up-regulation (about 3-fold) and subsequent down-
regulation of its expression within 20h of reoxygenation after 
hypoxia [108]. This result suggests that this protein may be 
one of the possible candidates for inducing the intracranial 
edema in the CNS after ischemia injury.  
2.6. AQP8 
  AQP8 expression was initially described in the testis, 
pancreas, placenta and liver [33]. By Northern Blot analysis, 
AQP8 RNA is not observed in the brain [33]. Nevertheless, 
AQP8 expression is observed in the spinal cord in particular 
in the ependymal cells lining the central canal and a faint 
staining in cells surrounding the canal suggesting a small 
amount of AQP8 expression in astrocytes too [65]. In a pre-
vious study AQP8 was found in astrocytes and in oligoden-
drocytes using RNase protection assay and the RT-PCR 
[108]. The expression pattern of AQP8 suggests that this 
protein may play a role in concert with AQP4 and AQP9 in 
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cular foot processes may participate in transport across the 
perivascular space, while AQP8 could then facilitate trans-
port into the central canal.  
2.7. AQP9 
  AQP9 is a water channel transporting glycerol, mannitol 
and urea. It was originally identified in human leukocytes 
[32], is also expressed in liver, testis, and brain [96]. In the 
brain, AQP9 is expressed in a subset of GFAP-positive 
ependymal cells lacking cilia, called tanycytes. The tany-
cytes are found in circumventricular organs of the third ven-
tricle lacking a BBB, such as the mediobasal hypothalamus, 
subfornical organ, and pineal gland [22, 61]. There are con-
flicting reports about AQP9 expression in the subset of cili-
ated ependymal cells [5, 22]. AQP9 is also expressed in as-
trocytes of the glia limitans and white matter tracts. In con-
trast to AQP4, which is expressed primarily in the foot-
processes of astrocytes, AQP9 is expressed throughout the 
astrocyte cell bodies and processes in the brain [5]. Like in 
the brain, AQP9 staining was found in the glia limitans and a 
subset of cells in the white matter tracts of the spinal cord 
[65].  
  AQP9 has been hypothesized to play a role in extracellu-
lar water homeostasis and edema formation similar to AQP4 
[5] and seems also to facilitate glycerol and monocarboxy-
late diffusion [14, 96]. As previously described by Badaut 
and colleagues [5], AQP9 could also play a role in clearing 
lactate from the extracellular space in pathological ischemic 
conditions such as stroke and spinal cord injury where lactic 
acidosis is common. Moreover the AQP9 immunoreactivity 
was found to be increased at the tumour border, but not 
within the tumour [103]. Nevertheless, in human glioblas-
toma most glioma cells throughout the tumour revealed a 
strong AQP9 expression across the whole surface of the 
cells. In human astrocytic tumours AQP9 expression were 
both increased compared with normal brain tissue for all 
grades of astrocytic tumours and that expression was greater 
in high-grade tumours than in low-grade ones [94]. The in-
crease of AQP9 expression may counteract the glioma-
associated lactic acidosis by clearance of glycerol and lactate 
from the extracellular space and could be involved in the 
energy metabolism of the glioma [103].  
  AQP9 may play an important role in the malignant pro-
gression of brain tumours and it can be used as a biomarker 
for molecular diagnosis and as a new target for gene therapy, 
but the molecular mechanisms by which AQP9 affects the 
proliferation and apoptosis of astrocytic tumours need to be 
studied further. 
CONCLUSIONS 
  The discovery of AQPs has provided a molecular basis 
for understanding water transport in a number of tissues in-
cluding the nervous system. In fact, emerging evidences 
suggest that brain AQPs play important roles for the dynamic 
regulation of brain water homeostasis and for the regulation 
of CSF. A tissue-specific pattern of AQP expression in the 
nervous system and in different type of glia cells, supports 
the idea that water movement in brain tissues is carefully 
regulated in concert with other transport processes from the 
micro- to macroscopic levels and that AQPs serve as ele-
ments of complex signaling assemblies. 
  Knock-out mice have confirmed the role of AQPs in 
transepithelial fluid transport, in cell migration, in regulation 
of glycerol and in forming CSF. Moreover, recent data sup-
port roles for AQPs in glial system, both in physiological 
and in pathophysiological conditions. Glial expression of 
AQPs is in fact altered in brain edema conditions and in 
presence of stroke, tumour and infection but also in neu-
rologic and neurodegenerative disease such as epilepsy, 
HIVD, autism and Alzheimer. 
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